Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY8RQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,218
Award facts
- Contract value 100% obligated
- $18,218.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,218.35 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of January 2, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of federal contract awards. The company's federal work predominantly involves delivery orders with the DLA Medical Supply Chain, covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award for Dupixent—a biologic medication for conditions such as atopic dermatitis and eosinophilic asthma—reflects the company's role in supplying specialized pharmaceutical commodities to support military healthcare systems and the Defense Health Agency.
Quick answers
Who was awarded contract SPE2DR26FY8RQ?
SPE2DR26FY8RQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FY8RQ worth?
The government has obligated $18,218 on SPE2DR26FY8RQ.
Is contract SPE2DR26FY8RQ an order under another contract?
Yes. SPE2DR26FY8RQ is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8RQ competed?
The extent of competition for SPE2DR26FY8RQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award